Growth factor therapy for decompensated cirrhosis: Much ado about nothing?
Cyriac Abby Philips, Philip Augustine, Sunil Mathew, Gopakumar C Valiathan, Solomon K John – 3 March 2018
Cyriac Abby Philips, Philip Augustine, Sunil Mathew, Gopakumar C Valiathan, Solomon K John – 3 March 2018
Lucy Golden‐Mason, Rachel H. McMahan, Michael S. Kriss, Alexandra L. Kilgore, Linling Cheng, Rachael J. Dran, Amanda Wieland, Hugo R. Rosen – 1 March 2018 – Chronic hepatitis C virus (HCV) infection is characterized by dysregulated natural killer (NK) cell responses. NKs play a critical role in achieving sustained responses to interferon (IFN)‐α‐based therapy. Rapid sustained HCV‐RNA clearance is now achieved with direct‐acting antivirals (DAAs). Studies of patients receiving first‐wave DAAs suggest NK functional restoration.
Grigoriy Shekhtman, Edmund Huang, Gabriel M. Danovitch, Paul Martin, Suphamai Bunnapradist – 1 March 2018 – In kidney‐alone recipients, dual‐kidney transplantation using “higher‐risk” donor organs has shown outcomes comparable to those of single‐kidney transplantation using extended criteria donor (ECD) organs.
Christian E. Oberkofler, Tim Reese, Dimitri A. Raptis, Christoph Kuemmerli, Olivier de Rougemont, Michelle L. De Oliveira, Andrea Schlegel, Philipp Dutkowski, Pierre‐Alain Clavien, Henrik Petrowsky – 1 March 2018 – Although the type of hepatic artery revascularization technique is known to have an impact on patency rates, independent perioperative risk factors on patient outcomes are poorly defined. All consecutive adult patients undergoing cadaveric liver transplantation (n = 361) from July 2007 to June 2016 in a single institution were analyzed.
Ryoichi Fujiwara – 1 March 2018
1 March 2018
Lisa B. VanWagner, Nancy Reau – 28 February 2018
Peter L. Abt, Kim M. Olthoff – 28 February 2018
Scott McHenry, Saad Alghamdi, Mauricio Lisker‐Melman – 28 February 2018
Samar H. Ibrahim, Keith D. Robertson – 28 February 2018